FP
PFE icon

FDO Partners’s Pfizer PFE Stock Holding History

FDO Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-20,053
Closed -$639K – 290
2017
Q2 		$639K Buy
20,053
+12,466
+164% +$393K 0.14% 198
2017
Q1 		$246K Sell
7,587
-23,803
-76% -$750K 0.06% 203
2016
Q4 		$967K Buy
+31,390
New +$958K 0.39% 107
2016
Q3 		– Sell
-16,695
Closed -$558K – 248
2016
Q2 		$558K Buy
16,695
+8,099
+94% +$258K 0.3% 134
2016
Q1 		$242K Sell
8,596
-36,110
-81% -$1.03M 0.16% 203
2015
Q4 		$1.37M Buy
+44,706
New +$1.41M 0.78% 28

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

FDO Partners's PFE Position: Q3 2017 in Review

FDO Partners sold out of Pfizer (PFE) in Q3 2017, closing a stake of 20,053 shares — an estimated $639K sold.

FDO Partners first reported a position in PFE in Q4 2015 and held it in 6 quarters. The position peaked at $1.37M in Q4 2015. 2,042 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • FDO Partners reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
  • FDO Partners sold 20,053 Pfizer shares in Q3 2017, an estimated $639K.
  • FDO Partners first reported a position in Pfizer in Q4 2015 and held it in 6 quarters.
  • FDO Partners's Pfizer position peaked at $1.37M in Q4 2015.
  • 2,042 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on FDO Partners's 13F filing for Q3 2017, filed 13 Nov 2017.